GameStop (NYSE:GME) on Friday reported Q1 results earlier than expected, with adjusted loss and revenue missing Wall Street ...

Spot gold (XAUUSD:CUR) fell 1.5% on Friday following reports that the People’s Bank of China paused their purchases in May ...

Hillenbrand, Inc. missed its Q2 earnings estimates and revised its fiscal 2024 outlook downward, causing its stock to decline ...

Dycom Industries' historical financial results have demonstrated strong financial performance. Learn why DY stock is a Buy.

Savara's valuation will be heavily impacted by the results of its upcoming IMPALA-2 trial for its drug Molgramostim. Learn ...

AGNC Investment's reliance on leverage and long-term fixed-income assets makes it vulnerable to interest rate fluctuations ...

Cracker Barrel is facing challenges in a competitive market, and it must revitalize its brand. See why we recommend a buy on ...

Thermo Fisher Scientific is well-positioned to benefit from the demand for innovation in the healthcare and biotech sectors.

Aegis Value Fund delivered a 13.13% return in 2023, underperforming the 23.33% gain in its primary benchmark small-cap deep ...

Uber's valuation is slightly above industry peers, which trade at a median EV/Sales TTM multiple of 3.2x (vs 3.6x for Uber).

Pfizer's growth in cancer treatments, acquisitions, R&D investment despite weak Q1 financials, and legal risks in mRNA ...

Stock futures were mixed as market participants awaited a key jobs report. Read more details on some stocks to watch on ...